Spots Global Cancer Trial Database for Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America

Official Title: Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America

Study ID: NCT05924789

Conditions

Gastric Cancer

GastroEsophageal Cancer

Pancreatic Cancer

Interventions

Observational study

Study Description

Brief Summary: Currently, there is no Brazilian or Latin American epidemiological data, such as clinical-pathological characteristics, standard treatments and outcomes of gastric cancer and pancreatic cancer in the region. The study aims to create a Latin American multicenter database to analyze epidemiological, clinical, and pathological data, treatments, outcomes, and biological information from patients with gastric and pancreatic cancer.

Detailed Description: Patients diagnosed with gastric and gastroesophageal junction or pancreatic cancer after January 2019 at participating sites will be included. Data will be collected from medical records in selected centers that comprise different countries from Latin America. Data collection will begin on the time of site activation. Patients recruited for this study will be identified in the participating sites. Data from clinical, demographic, and socioeconomic variables will be collected. Also, data on treatments performed and outcomes will be abstracted. The patient data sources will be the medical records of the patients. Patients will continue to receive treatment and clinical evaluations for gastric and gastroesophageal junction or pancreatic cancer according to what is determined by their medical team, according to the usual standards of treatment and clinical practice of each center.